Opioid-Related Disorders: all 1,439 studies
Page 14 of 15. Open to participants first (291), then studies with results posted, then the rest; newest registration first within each.
- Clonidine for Relapse Prevention in Buprenorphine-Maintenance PatientsCompletedNCT00295308Phase 1
- Real Time Assessment of Drug Craving, Use, and Abstinence During Outpatient: A Development and Feasibility StudyCompletedNCT00292136
- Combined Behavioral and Pharmacologic Treatment of Polydrug AbuseCompletedNCT00292123Phase 1
- The German Project of Heroin Assisted Treatment of Opiate Dependent PatientsCompletedNCT00268814Phase 3
- Integrating Buprenorphine Into the SFGH AIDS ProgramCompletedNCT00263458Phase 4
- Medication Adherence Therapy for Opioid Abusing Pain PatientsCompletedNCT00249587Phase 1/2
- Employment-based Reinforcement to Motivate Drug Abstinence in the Treatment of Drug Addiction. - 2CompletedNCT00249457Not applicable
- A Video-Based HCV Curriculum for Active Injection Drug UsersCompletedNCT00241943Not applicable
- Integrating Buprenorphine Into HIV TreatmentStatus unknownNCT00241930Phase 4
- A Video-Based HCV Curriculum for Drug UsersCompletedNCT00241917Not applicable
- Opiate Dependence: Combined Naltrexone/Behavior Therapy - 1CompletedNCT00238914Phase 2
- Interactive Voice Response (IVR) for Methadone PatientsCompletedNCT00237406
- Lofexidine for Inpatient Opiate DetoxCompletedNCT00235729Phase 3
- The CORE Buprenorphine Project - An HIV Primary Care Program DemonstrationCompletedNCT00227357
- The Effects of Methadone and Buprenorphine on Fetal Neurobehavior and Infant Neonatal Abstinence Syndrome - 1CompletedNCT00218621
- Disulfiram for Treating Cocaine Dependence in Individuals Maintained on MethadoneCompletedNCT00218608Phase 2
- Dextromethorphan, Gabapentin, and Oxycodone to Treat Opioid-Induced HyperalgesiaCompletedNCT00218374Not applicable
- Effects of Post-Session Supplemental Hydromorphone on Drug Seeking Behavior in Opioid Dependent IndividualsCompletedNCT00218361
- Effects of Pre-Session Supplemental Hydromorphone on Drug Seeking Behavior in Opioid Dependent IndividualsCompletedNCT00218309
- Treatment of Opioid/Heroin Dependence: Comparison of Three Medication Dosing RegimensCompletedNCT00218127Phase 2
- Buprenorphine as a Treatment for Individuals Dependent on Analgesic OpioidsCompletedNCT00218101Phase 2
- Methadone Levels in Breast Milk of Women Taking Methadone for Opiate Addiction - 2CompletedNCT00218010
- Naltrexone Implants vs. MMT Among Inmates in the Norwegian Correctional ServicesCompletedNCT00204243Phase 2
- Applying Web Technology to Buprenorphine TreatmentStatus unknownNCT00182598Not applicable
- Science-Based Treatment for Opioid-Dependent AdolescentsStatus unknownNCT00182572Phase 2
- NAOMI: A Study to Compare Medically-prescribed Heroin With Oral Methadone in Chronic Opiate AddictionCompletedNCT00175357Phase 3
- Bone Density and Serum Testosterone in Male Methadone Maintained PatientsCompletedNCT00170339
- The Efficacy of Methadyl Acetate (LAAM) and Contingency Management Procedures for Treating Dual Opioid and Cocaine Abuse - 1CompletedNCT00158288Phase 2
- Abuse Potential of Buprenorphine and Naloxone in Non-Dependent Opioid UsersCompletedNCT00158236Not applicable
- Abuse Potential of Buprenorphine/NaloxoneTerminatedNCT00149539Phase 2
- HEPMET-1: Evaluate the Feasibility, Mental Sideeffects and the Efficacy of Hepatitis C Treatment in a MMT Group.CompletedNCT00147784Phase 3
- Tramadol to Reduce Opioid Withdrawal SymptomsCompletedNCT00142896Phase 2
- Fluoxetine to Reduce Cocaine Use in Cocaine and Opioid AddictsCompletedNCT00142779Not applicable
- Opioid Agonist and Antagonist Effects on Opioid DependenceTerminatedNCT00142727Phase 2
- Addition of Naltrexone to Methadone TaperCompletedNCT00135759Phase 2
- Effects of Buprenorphine/Naloxone Administered in Different Ways For Treating Opioid DependenceCompletedNCT00134914Not applicable
- Blockade Efficacy of Buprenorphine/Naloxone For Opioid DependenceCompletedNCT00134888Not applicable
- Assessing Abuse Potential of Parenteral Buprenorphine/Naloxone in Non-Dependent Opioid AbusersTerminatedNCT00134875Not applicable
- Comparison of HIV Clinic-based Treatment With Buprenorphine Versus Referred Care in Heroin-dependent ParticipantsCompletedNCT00130819Phase 2
- Effectiveness of Tiagabine for Cocaine Dependence in Methadone-Maintained Individuals - 1CompletedNCT00129298Phase 2
- Buprenorphine and Integrated HIV Care EvaluationStatus unknownNCT00124358Phase 4
- Evaluation of DBT Compared to Drug Counseling for Opiate AddictsCompletedNCT00117741Not applicable
- Buprenorphine/Naloxone - Facilitated Rehabilitation for Opioid Dependent Adolescents - 1CompletedNCT00078130Phase 3
- Suboxone: (Buprenorphine/Naloxone) Comparison of Two Taper Schedules - 1CompletedNCT00078117Phase 3
- Fetal Neurobehavioral Development in Methadone Maintained PregnanciesCompletedNCT00067184
- HIV Counseling Intervention for Methadone-Maintained Patients - 2CompletedNCT00061100Phase 1
- Treatment of Adult Attention Deficit Hyperactivity Disorder (ADHD) in Methadone Patients - 1CompletedNCT00061087Phase 2/3
- Lofexidine for Opiate Withdrawal - 1CompletedNCT00032942Phase 3
- Counseling Conditions for Buprenorphine in a Primary Care Clinic - 1CompletedNCT00023283Phase 2
- Effect Of Case Management Following Discharge From Methadone TreatmentCompletedNCT00018226Phase 2
- Buprenorphine/Naloxone in the Treatment of Heroin Dependence - 14CompletedNCT00015340Phase 4
- Buprenorphine and Naloxone Combination Study - 10CompletedNCT00015288Phase 1
- Buprenorphine and Naloxone for the Treatment of Opiate Dependence - 1CompletedNCT00015171Phase 3
- Buprenorphine Dose Escalation Trial for Treatment of Non-Dependent Opiate Users - 2CompletedNCT00015041Phase 1
- Buprenorphine/Naloxone for Opiate-Dependence Treatment - 1CompletedNCT00015028Phase 2
- Determine the Safety of a Sublingual Tablet Formulation of Buprenorphine and Naloxone by Extending the Combination Tablet Availability to Physicians in Office-Based PracticeCompletedNCT00007527Phase 4
- Evaluation of Lofexidine for Treatment of Opioid Withdrawal - 7CompletedNCT00000358Phase 1
- Buprenorphine Maintenance for Opiate Dependence - 6CompletedNCT00000357Phase 2
- Evaluation of L-alpha-acetylmethadol (LAAM) in Methadone Patients - 5CompletedNCT00000356Phase 2
- Effects of Buprenorphine and Naloxone in Opiate Addicts - 4CompletedNCT00000355Phase 1
- Evaluation of Lofexidine for Treatment of Opioid Withdrawal - 3CompletedNCT00000354Phase 1
- Trial of Buprenorphine/Naloxone for Opiate Dependence - 2CompletedNCT00000353Phase 2
- Effects of Dextromethorphan on Opioid Tolerance in Methadone Patients - 1CompletedNCT00000352Phase 2
- Evaluation of Lofexidine for Treatment of Opiate Withdrawal - 10CompletedNCT00000345Phase 1
- Buprenorphine/Naloxone for Treatment of Opiate Dependence - 9CompletedNCT00000344Phase 2
- Evaluation of Liquid vs. Tablet Buprenorphine - 6CompletedNCT00000341Phase 2
- Activity Monitoring Assessment of Opiate Withdrawal - 4CompletedNCT00000335Phase 2
- Comparison of Buprenorphine and Methadone - 3CompletedNCT00000334Phase 2
- Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-3 - 6WithdrawnNCT00000331Phase 2
- Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-2 - 5WithdrawnNCT00000330Phase 2
- Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-1 - 4WithdrawnNCT00000329Phase 2
- Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment III) - 3WithdrawnNCT00000328Phase 2
- Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment I(2) - 2WithdrawnNCT00000327Phase 2
- Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment 1 - 1WithdrawnNCT00000326Phase 2
- Buprenorphine Formulation Comparison: Sublingual Tablet vs. Solution - 1CompletedNCT00000320Phase 1/2
- Buprenorphine Maintenance Dose Schedule and Treatment Setting - 2CompletedNCT00000319Phase 2
- Buprenorphine Maintenance Dose Schedule and Treatment Setting - 1CompletedNCT00000318Phase 2
- Combining Behavioral Treatment With Agonist Maintenance - 1CompletedNCT00000311Phase 3
- Dextroamphetamine as Adjunct in Cocaine/Opiate Dependent Patients - 3CompletedNCT00000306Phase 2
- Feasibility Study of Take-Home LAAM Medication - 3CompletedNCT00000300Phase 4
- Rapid Opiate Detoxification and Naltrexone Induction Using Buprenorphine - 2CompletedNCT00000299Phase 2
- Buprenorphine Combination Tablet Feasibility - 1CompletedNCT00000298Phase 2
- Novel Medications for Opiate Detoxification - 4CompletedNCT00000279Phase 2
- A Laboratory Model for Heroin Abuse Medications - 8CompletedNCT00000273Phase 2
- Subjective Effects of Nitrous Oxide in Dental Patients - 17CompletedNCT00000265
- Subjective/Psychomotor/ Effects of Combined Alcohol & Nitrous Oxide - 16CompletedNCT00000264Not applicable
- Effects of Combined Alcohol and Nitrous Oxide Intake - 15CompletedNCT00000263Not applicable
- Effects of Combined Sevoflurane and Nitrous Oxide Inhalation - 14CompletedNCT00000262Not applicable
- Effects of Alcohol History on Effects of Sevoflurane and Nitrous Oxide - 13CompletedNCT00000261Phase 2
- Effects of Behavioral Contingencies on Effects of Nitrous Oxide - 12CompletedNCT00000260Not applicable
- Sevoflurane vs Nitrous Oxide Inhalation at Subanesthetic Concentrations - 11CompletedNCT00000259Not applicable
- Role of Instructions in Nitrous Oxide Effects and Choice - 10CompletedNCT00000258Not applicable
- Effects of Alcohol History on Effects of Nitrous Oxide - 9CompletedNCT00000257Not applicable
- Reinforcing Effects of Brief Exposures to Nitrous Oxide - 8CompletedNCT00000256Not applicable
- Differential Acute Tolerance Development to Effects of Nitrous Oxide - 7CompletedNCT00000255Phase 2
- Isoflurane at Subanesthetic Concentrations - 6CompletedNCT00000254Phase 2
- Effects of Nitrous Oxide: A Dose-Response Analysis - 5CompletedNCT00000253Not applicable
- Lack of Acute Tolerance Development to Effects of Nitrous Oxide - 4CompletedNCT00000252Phase 2
- Effects of Subanesthetic Concentrations of Isoflurane/Nitrous Oxide - 3CompletedNCT00000251Phase 2
- Cold Water Immersion Modulates Reinforcing Effects of Nitrous Oxide - 2CompletedNCT00000250Phase 2